Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-20

Clinical Trial Update: A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients [Phase 4]

View source ↗

Summary

This Phase 4 pragmatic randomized trial evaluated the comparative effectiveness of dapagliflozin versus standard of care in adults with type 2 diabetes mellitus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: University of Liverpool | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED